Warmest congratulations on the successful holding of the Left Atrial Appendage Closure Device Training Workshop by Poco International Medical Trading (Shanghai) Co., Ltd. at Guorui Xin Chuang!
Release time:
2022-05-30 17:35
Keywords:
Occluder, Left Atrial Appendage, Medical Device, Healthcare, Shanghai, Company, Evaluation, Experiment, Limited Liability Company, International
2022 Year 05 Moon 13 Date to 14 On [date], the two-day training workshop on left atrial appendage closure devices for experimental animals, organized by Boston Scientific International Medical Trade (Shanghai) Co., Ltd., was successfully held at Shaanxi Guorui Xinchuang Medical Technology Co., Ltd. Boston Scientific invited relevant experts, professors, and technical personnel from institutions including Xijing Hospital, the First Affiliated Hospital of Xi'an Jiaotong University, and Xi'an International Medical Center to conduct hands-on surgical procedures—including animal experiments, simulator demonstrations, and cardiac dissections—at Guorui Xinchuang’s medical device laboratory. Following the practical sessions, an experimental discussion was held in the conference room. Guorui Xinchuang provided assistance with the supply of experimental animals, surgical assistants, and conference services.
Regarding Left Atrial Appendage Closure:
Left Atrial Appendage Closure (LAAO) LAAC The procedure, also known as left atrial appendage closure via intervention, involves percutaneous puncture of the femoral vein using an interventional approach. A domestically produced or imported disc- or plug-type occluder is then delivered through the femoral vein to the left atrial appendage, where it is deployed to effectively seal off the appendage, thereby preventing thrombus formation and reducing the risk of embolic events. LAAC The procedure boasts precise efficacy, minimal trauma, no significant pain, rapid recovery, high safety, and a high success rate.
About Poco International Medical Trading (Shanghai) Co., Ltd.:
Boco International Medical Trade (Shanghai) Co., Ltd. is Boston Scientific’s Greater China region. Boston Scientific was... 1997 The company established its China regional headquarters in Shanghai and currently has branch offices in Beijing, Shanghai, Guangzhou, Chengdu, Hong Kong, and Taiwan. Its core business areas include cardiac intervention, structural heart disease, cardiac rhythm management and electrophysiology, endoscopic intervention, peripheral and oncology intervention, urology and pelvic floor health, and respiratory products. Upholding its tradition as an innovation leader, Boston Scientific is committed to becoming a medical technology company that closely meets the needs of both physicians and patients, remains dynamically innovative, and earns widespread respect by providing high-quality medical products and services across prevention, diagnosis, and treatment.
About Guorui Xinchuang:
Guo Rui Xin Chuang is an independent, third-party clinical preclinical safety evaluation research institution for medical devices, established in... 2020 Year 6 Yue was registered and established in the Airport New City Airside Industrial Park. It is currently the largest and most powerful medical device safety evaluation institution in Northwest China, primarily providing product safety evaluation services to R&D companies of Class II and Class III medical devices.
2021 Year 3 It has been awarded the “License for the Use of Laboratory Animals” by the Shaanxi Provincial Department of Science and Technology, making it the only institution in our province that complies with... GLP Preclinical Evaluation Laboratory for Medical Devices in Operation.
As an important intermediate link in the transformation of innovative medical devices from the innovation chain to the industrial chain, medical device safety evaluation research bridges the interaction and integration between the innovation chain and the industrial chain in the life sciences sector under the Qin Chuang Yuan initiative, and thus holds significant value for the development of the province’s life sciences industry.
Related News
Contact phone number
Ms. Li:+86 15760970681
Mr. Su:+86 19991001701
Landline:+86-29-33656828
Company Address
4th Floor, Unit C. Building 9. Small and Medium-sized
Enterprise Park, Airport Industrial Zone Airport New Ciy,Xixian New Area, Shaanxi Province
©2026 Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd.
WhatsApp：8613940397353
Email：hr-xian@grglp.com
Landline：862933656828
Mr. Su：8619991001701
Ms. Li：8615760970681